Versant Capital Management’s 10x Genomics TXG Stock Holding History

Versant Capital Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	29,559 -14,912	-34%	-$391K	0.1%	116
2026 Q1	$944K	Buy	44,471 +10,193	+30%	+$204K	0.09%	133
2025 Q4	$559K	Buy	34,278 +4,914	+17%	+$74.2K	0.07%	197
2025 Q3	$343K	Buy	29,364 +945	+3%	+$12.3K	0.05%	318
2025 Q2	$329K	Buy	28,419 +16,337	+135%	+$149K	0.05%	295
2025 Q1	$105K	Buy	12,082 +11,800	+4,184%	+$149K	0.02%	608
2024 Q4	$4.05K	Sell	282 -1,323	-82%	-$20.9K	﹤0.01%	1858
2024 Q3	$36.2K	Buy	1,605 +1,400	+683%	+$28.9K	0.01%	561
2024 Q2	$3.99K	Buy	+205	New	+$5.37K	﹤0.01%	1292
2022 Q1	–	Sell	-2	Closed	–	–	1631
2021 Q4	$0	Buy	+2	New	+$306	﹤0.01%	1590

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

VWM

Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

Versant Capital Management's TXG Position: Q2 2026 in Review

Versant Capital Management reduced its 10x Genomics (TXG) stake by 34% in Q2 2026, selling an estimated $391K and leaving 29,559 shares worth $1.13M. The position accounts for 0.1% of the portfolio, ranked #116.

Versant Capital Management first reported a position in TXG in Q4 2021 and has held it in 10 quarters since. 38 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Versant Capital Management held 29,559 shares of 10x Genomics worth $1.13M as of Q2 2026.
Versant Capital Management sold 14,912 10x Genomics shares in Q2 2026, an estimated $391K.
10x Genomics made up 0.1% of Versant Capital Management's portfolio in Q2 2026, its #116 holding.
Versant Capital Management first reported a position in 10x Genomics in Q4 2021 and has held it in 10 quarters since.
38 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.